5.2 Acute Coronary Syndromes, Heart Failure & Shock Classifications

5.2 Acute Coronary Syndromes, Heart Failure & Shock Classifications

Quick Answer: Acute Coronary Syndromes (ACS) encompass a pathophysiological continuum from unstable angina to NSTEMI and STEMI, distinguished by clinical presentation, 12-lead ECG findings, and cardiac troponin biomarker kinetics. Emergency nursing management prioritizes the rapid MONA protocol, timely reperfusion (door-to-balloon PCI within 90 minutes or fibrinolysis within 30 minutes), and continuous cardiac rhythm monitoring. Heart failure manifests with distinct hemodynamic profiles: left-sided failure causes pulmonary vascular congestion, while right-sided failure leads to systemic venous overload; both require strict daily weight monitoring, sodium restriction, and careful administration of loop diuretics, ACE inhibitors, and digoxin while monitoring for toxicity. Shock represents systemic cellular hypoperfusion categorized into hypovolemic, cardiogenic, distributive (septic, anaphylactic, neurogenic), and obstructive shock, each evolving through four progressive pathophysiological stages requiring rapid targeted fluid resuscitation, vasopressors, and inotropic support.

---

The Spectrum of Coronary Artery Disease and Acute Coronary Syndromes

Coronary Artery Disease (CAD) arises from progressive atherosclerotic plaque accumulation within the epicardial coronary arteries. When an unstable, lipid-rich atheromatous plaque undergoes superficial erosion, ulceration, or frank rupture, subendothelial collagen is exposed to circulating platelets. Platelet activation, adhesion, and thrombin generation precipitate acute intraluminal coronary thrombosis, creating the clinical spectrum of Acute Coronary Syndromes (ACS).

                       ATHEROSCLEROTIC PLAQUE RUPTURE
                                     |
                                     v
                       PLATELET ACTIVATION & THROMBOSIS
                                     |
                  +------------------+------------------+
                  |                                     |
          PARTIAL OCCLUSION                     COMPLETE OCCLUSION
                  |                                     |
         +--------+--------+                            v
         |                 |                          STEMI
         v                 v                (Persistent ST-elevation,
  UNSTABLE ANGINA        NSTEMI              transmural necrosis,
 (No biomarkers;       (Troponin elevated;   positive troponin)
  ischemia at rest)     ST-depression/T-inv)

---

Diagnostic Triad of Acute Myocardial Infarction

Definitive diagnosis of acute myocardial infarction requires at least two of the following three elements:

1. Clinical History: Heavy, retrosternal chest pressure, squeezing, fullness, or aching pain, frequently radiating to the left shoulder, left arm, neck, lower jaw, or epigastrium. Accompanied by profuse diaphoresis, dyspnea, nausea, vomiting, dizziness, and Levine's sign (patient holding a clenched fist over the sternum).
   • Atypical Presentations: Female, elderly, and diabetic patients frequently present without chest pain ("silent ischemia"), reporting isolated dyspnea, unexplained fatigue, syncope, nausea, or epigastric discomfort.
2. 12-Lead Electrocardiogram (ECG):
   • Hyperacute T Waves: Tall, peaked, symmetrical T waves developing within minutes of arterial occlusion;
   • ST-Segment Elevation: Indicates acute transmural myocardial injury (epicardial injury current);
   • Pathological Q Waves: Development of Q waves >= 0.04 seconds (one small box) in duration and >= 25% of the total R-wave amplitude, signifying irreversible full-thickness myocardial necrosis.
3. Cardiac Biomarkers:
   • Cardiac Troponins (cTnI and cTnT): Highly specific, gold-standard contractile regulatory proteins. Serum levels rise within 3 to 4 hours following myocardial injury, peak at 12 to 24 hours, and remain elevated for 7 to 14 days, providing a wide diagnostic window;
   • Creatine Kinase-MB (CK-MB): Rises within 4 to 6 hours, peaks at 18 to 24 hours, and returns to normal baseline within 48 to 72 hours. CK-MB is clinically valuable for diagnosing early re-infarction (recurrent ischemia occurring several days after the initial event when troponin levels remain elevated from the primary insult).

---

Emergency Acute Nursing Management & Reperfusion Windows

The Immediate Resuscitation Protocol

Upon suspecting an acute coronary syndrome, immediate actions must be instituted without delay:

+--------------------------------------------------------------------------+
|                      EMERGENCY ACS NURSING PRIORITIES                     |
+--------------------------------------------------------------------------+
| - Aspirin (ASA):        160 to 325 mg non-enteric coated tablet chewed   |
|                         immediately (inhibits thromboxane A2).           |
|                                                                          |
| - Oxygen Therapy:       Indicated ONLY if SpO2 < 90% or patient in       |
|                         respiratory distress (hyperoxia triggers         |
|                         coronary vasoconstriction and reperfusion injury)|
|                                                                          |
| - Nitroglycerin (NTG):  0.4 mg sublingual tablet every 5 min (max 3      |
|                         doses). Dilates coronary arteries and veins.     |
|                                                                          |
| - Morphine Sulfate:     2 to 4 mg slow IV push for refractory chest pain |
|                         and pulmonary congestion; reduces preload.       |
+--------------------------------------------------------------------------+

[!CAUTION] Critical Contraindications for Nitroglycerin: Nurses must never administer nitrates if:

1. Systolic blood pressure is < 90 mmHg or heart rate is < 50 bpm;
2. The patient has ingested a Phosphodiesterase-5 (PDE-5) inhibitor (e.g., sildenafil, vardenafil within 24 hours, or tadalafil within 48 hours), as this combination triggers catastrophic, refractory vasodilation and fatal cardiovascular collapse;
3. An inferior-wall STEMI with right ventricular (RV) infarction is present (leads II, III, aVF, and right-sided V4R elevation). The ischemic right ventricle is highly preload-dependent; nitrates precipitously drop preload, inducing profound cardiogenic shock.

Time-Critical Reperfusion Windows

Myocardial salvage is strictly time-dependent ("time is muscle"):

• Percutaneous Coronary Intervention (PCI): The gold-standard mechanical reperfusion method (balloon angioplasty with drug-eluting stent placement). Goal: Door-to-balloon time < 90 minutes at a PCI-capable center, or < 120 minutes if requiring inter-facility transfer.
• Thrombolytic / Fibrinolytic Therapy: Intravenous administration of tissue plasminogen activator (Alteplase, Tenecteplase, or Streptokinase) indicated when primary PCI cannot be delivered within 120 minutes. Goal: Door-to-needle time < 30 minutes.
  • Absolute Contraindications to Fibrinolysis: Prior intracranial hemorrhage, known structural cerebral vascular malformation (AVM), malignant intracranial neoplasm, ischemic stroke within 3 months, active internal bleeding, or suspected aortic dissection.

---

Heart Failure: Left-Sided vs. Right-Sided Heart Failure

Heart failure (HF) is a complex clinical syndrome resulting from structural or functional cardiac impairment, leading to elevated intracardiac pressures and inadequate systemic perfusion at rest or during physiological stress.

LEFT-SIDED HEART FAILURE               RIGHT-SIDED HEART FAILURE
(Left Ventricular Failure)             (Cor Pulmonale / RV Failure)
           |                                       |
           v                                       v
Elevated LV End-Diastolic Pressure       Elevated RV End-Diastolic Pressure
           |                                       |
           v                                       v
Backward Pressure into Pulmonary Veins   Backward Pressure into Systemic Veins
           |                                       |
           v                                       v
PULMONARY CONGESTION & EDEMA             SYSTEMIC VENOUS CONGESTION
- Dyspnea & Orthopnea                    - Jugular Venous Distention (JVD)
- Paroxysmal Nocturnal Dyspnea (PND)     - Dependent Peripheral Edema
- Bilateral Basilar Crackles (Rales)     - Hepatomegaly & Ascites
- Cough with Pink Frothy Sputum          - Hepatojugular Reflux & Weight Gain

Clinical Comparison of Failure Manifestations

• Left-Sided Heart Failure (Pulmonary Manifestations):
  • Dyspnea and Tachypnea: Due to pulmonary vascular congestion and fluid accumulation in alveolar spaces;
  • Orthopnea: Dyspnea provoked by lying supine, relieved by sitting upright; quantified by the number of pillows required to sleep;
  • Paroxysmal Nocturnal Dyspnea (PND): Severe, sudden shortness of breath awakening the patient from sleep 1 to 2 hours after recumbency, caused by central redistribution of dependent interstitial fluid;
  • Auscultation: Bibasilar inspiratory crackles (crepitations), wheezes ("cardiac asthma"), and an audible S3 ventricular gallop reflecting volume overload in a non-compliant ventricle;
  • Acute Pulmonary Edema: Extreme dyspnea, cyanosis, diaphoresis, air hunger, and production of copious, thin, pink, frothy sputum.
• Right-Sided Heart Failure (Systemic Manifestations):
  • The most common cause of right-sided heart failure is pre-existing left-sided heart failure (pulmonary hypertension backward failure);
  • Jugular Venous Distention (JVD): Elevation of internal jugular venous pulsation > 4 cm above the sternal angle at 45 degrees inclination;
  • Dependent Peripheral Edema: Symmetrical, pitting edema developing in gravity-dependent areas (ankles and pretibial regions in ambulatory patients; presacral area in bedridden patients);
  • Hepatomegaly and Splenomegaly: Painful hepatic enlargement due to venous congestion, positive hepatojugular reflux, and ascites;
  • Gastrointestinal Congestion: Anorexia, nausea, abdominal bloating, and early satiety.

Medical and Nursing Management of Heart Failure

1. Hemodynamic & Weight Monitoring: Daily weights taken at the same time each morning using the same scale, after voiding and before breakfast. A weight gain of > 1 to 2 kg (2 to 3 lbs) in 24 hours or > 2.5 kg (5 lbs) in one week indicates acute fluid retention and warrants urgent diuretic adjustment;
2. Dietary Restrictions: Sodium restriction (< 2 g elemental sodium per day) to minimize fluid retention; fluid restriction (1.5 to 2.0 L/day) in advanced or hyponatremic heart failure;
3. Loop Diuretics (Furosemide): Potent intravenous or oral diuretic inhibiting the Na-K-2Cl cotransporter in the thick ascending limb of Henle. Promotes rapid diuresis and preload reduction. Nursing focus: Monitor for hypokalemia, hyponatremia, dehydration, hypotension, and ototoxicity (with rapid IV boluses);
4. ACE Inhibitors (e.g., Lisinopril) & ARBs: Reduce afterload via arterial vasodilation and block aldosterone-mediated remodeling. Monitor for hyperkalemia, acute kidney injury, dry cough, and angioedema;
5. Beta-Blockers (e.g., Carvedilol, Bisoprolol, Metoprolol succinate): Inhibit sympathetic overdrive and reverse cardiac remodeling. Must be introduced slowly in clinically euvolemic, stable patients; never initiate or up-titrate during acute decompensated cardiogenic shock;
6. Digoxin Monitoring & Toxicity Protocols:
   • Positive inotropic, negative chronotropic cardiac glycoside that improves cardiac contractility while slowing AV nodal conduction;
   • Therapeutic Serum Concentration: 0.5 to 2.0 ng/mL (narrow therapeutic index);
   • Nursing Administration Rule: Always auscultate the apical pulse for a full 60 seconds prior to administration; hold the dose and notify the physician if the apical pulse is < 60 beats per minute in an adult (or < 90 bpm in an infant);
   • Manifestations of Digitalis Toxicity:
     • Gastrointestinal: Anorexia (earliest sign), nausea, vomiting, diarrhea;
     • Neurological: Fatigue, confusion, headache, drowsiness;
     • Visual Disturbances: Blurred vision, photophobia, and characteristic yellow-green halos (xanthopsia) around objects or lights;
     • Cardiac: Sinus bradycardia, premature ventricular contractions (bigeminy), AV block, and life-threatening ventricular tachycardia.
   • Electrolyte Alert: Hypokalemia (< 3.5 mmol/L) dramatically heightens myocardial sensitivity to digoxin, precipitating fatal toxicity even at normal therapeutic serum digoxin concentrations. Hypomagnesemia and hypercalcemia also enhance toxicity.

---

Classifications of Shock

Shock is a life-threatening, generalized state of systemic hypoperfusion characterized by the failure of the circulatory system to deliver sufficient oxygenated blood to satisfy cellular metabolic requirements, resulting in cellular dysoxia, anaerobic metabolism, and lactic acidosis.

+---------------------------------------------------------------------------------+
|                            FOUR PRIMARY TYPES OF SHOCK                          |
+---------------------------------------------------------------------------------+
| 1. HYPOVOLEMIC:  Absolute loss of intravascular circulating blood or fluid       |
|                  volume (e.g., hemorrhagic trauma, burns, severe cholera).      |
|                                                                                 |
| 2. CARDIOGENIC:   Primary mechanical pump failure of the myocardium with         |
|                  inadequate cardiac output despite adequate volume (e.g., MI).   |
|                                                                                 |
| 3. DISTRIBUTIVE:  Profound systemic vasodilation and capillary leak resulting    |
|                  in severe relative hypovolemia (Septic, Anaphylactic,          |
|                  Neurogenic).                                                   |
|                                                                                 |
| 4. OBSTRUCTIVE:   Physical mechanical impediment to ventricular filling or       |
|                  cardiac outflow (Tamponade, Tension Pneumothorax, Massive PE). |
+---------------------------------------------------------------------------------+

Clinical and Hemodynamic Profiles

• Hypovolemic Shock: Characterized by low central venous pressure (CVP), low pulmonary capillary wedge pressure (PCWP), low cardiac output (CO), and compensatory high systemic vascular resistance (SVR). Patients are tachycardic, tachypneic, with cool, pale, clammy extremities, delayed capillary refill (> 3 seconds), and oliguria (< 0.5 mL/kg/h);
• Cardiogenic Shock: Characterized by elevated filling pressures (high CVP and PCWP), severely depressed cardiac output (cardiac index < 2.2 L/min/m2), and high SVR. Manifests with hypotension, pulmonary crackles, S3 gallop, and cold extremities;
• Distributive Shock Subtypes:
  • Septic Shock: Dysregulated host response to infection with refractory hypotension requiring vasopressors to maintain a Mean Arterial Pressure (MAP) >= 65 mmHg and serum lactate > 2 mmol/L despite adequate fluid resuscitation (30 mL/kg crystalloid). Early ("warm") phase exhibits hyperdynamic high CO and low SVR (warm, flushed skin); late ("cold") phase features myocardial depression and peripheral vasoconstriction;
  • Anaphylactic Shock: Severe IgE-mediated type I hypersensitivity reaction causing massive mast cell degranulation. Massive histamine release triggers systemic vasodilation, profound capillary permeability, laryngeal edema, and severe bronchospasm. Immediate first-line drug: Intramuscular Epinephrine (Adrenaline) 1:1,000 (0.3 to 0.5 mg) injected into the anterolateral mid-thigh;
  • Neurogenic Shock: Results from acute spinal cord injury at or above T6, disrupting sympathetic outflow. Hallmark clinical triad: Hypotension, Bradycardia, and Warm, Dry Skin (due to complete loss of vasomotor tone and unopposed parasympathetic vagal stimulation);
• Obstructive Shock: Caused by extrinsic compression:
  • Cardiac Tamponade: Beck's triad (hypotension, jugular venous distention, muffled heart sounds) and pulsus paradoxus;
  • Tension Pneumothorax: Severe respiratory distress, unilateral absent breath sounds, tracheal deviation to the contralateral side;
  • Massive Pulmonary Embolism: Acute RV strain, severe hypoxemia, acute cor pulmonale.

Pathophysiological Stages of Shock

1. Initial Stage: Cellular hypoperfusion without overt clinical symptoms; metabolic transition from aerobic to anaerobic metabolism produces lactic acid;
2. Compensatory Stage: Neural, hormonal, and chemical compensatory mechanisms are activated (sympathetic stimulation, RAAS activation, ADH release) to maintain cerebral and coronary perfusion. Manifests as tachycardia, tachypnea, peripheral vasoconstriction (pale, cool skin), normal or mildly decreased systolic blood pressure, and decreased urine output;
3. Progressive Stage: Compensatory mechanisms fail. Tissue perfusion becomes profoundly compromised; capillary permeability leads to widespread interstitial edema; mean arterial pressure falls < 60 mmHg; profound lactic acidosis, oliguria, somnolence, and dysrhythmias develop;
4. Irreversible (Refractory) Stage: Profound cellular destruction, severe metabolic acidosis, and microvascular thrombosis lead to Multiple Organ Dysfunction Syndrome (MODS). The patient is unresponsive to fluids, inotropes, and vasopressors; clinical demise is inevitable.

Resuscitation Priorities

• Airway & Ventilation: Secure a patent airway; deliver high-flow supplemental oxygen or initiate mechanical ventilation to decrease oxygen consumption;
• Intravascular Volume Expansion: Rapid infusion of isotonic crystalloids (0.9% Normal Saline or Ringer's Lactate) at 30 mL/kg within the first 3 hours for hypovolemic and septic shock. Boluses must be given with extreme caution in cardiogenic shock;
• Vasoactive Drug Support: When fluid resuscitation fails to restore MAP >= 65 mmHg:
  • Norepinephrine (Levophed): First-line potent alpha-1 adrenergic vasopressor in septic and distributive shock;
  • Dobutamine: First-line inotropic agent for cardiogenic shock to augment myocardial contractility;
  • Epinephrine: Mandatory in anaphylaxis and refractory shock.